Friday December 13, 2019

Private patients get cancer drugs denied to public for first time

Oncologist John Crown says the move is ‘unprecedented’ and calls on Minister for Health to ‘extend the opportunity of treatment to all patients’

Susan Mitchell

Deputy Editor and Health Editor

14th April, 2019

Patients with VHI health insurance are now able to access new cancer drugs that are not available to public patients, creating an official two-tier divide for “the first time”.

VHI, the biggest health insurer in the country, wrote to oncologists in recent days stating that it was extending access to innovative new drugs for patients with melanoma, breast cancer and lung cancer.

The HSE is only funding those drugs for patients with very...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Patient advocates are unhappy with the latest report on the national cervical screening programme and want further reviews, but some medical experts say resources would be better used elsewhere

Susan Mitchell | 5 days ago

Britain’s so-called ‘election of a generation’ is as muddled and confused as the Brexit debate that preceded it. On the ground in a number of constituencies, it proves difficult to take the temperature of this strangest of political contests

Susan O'Keeffe | 5 days ago

Undisclosed pay deals, secret pensions and underpayment of tax are just some of the problems left by John Delaney, as last week’s press conference revealed that the FAI has a long road ahead of it

Róisín Burke | 5 days ago